UNSPSC 51171725: Loperamide oxide monohydrate

This classification denotes an opioid and antidiarrheal agent with the molecular formula C29H33ClN2O3.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier H3VOT77DE1, chemically known as 1-piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-n,n-dimethyl-alpha,alpha-diphenyl-, 1-oxide, (e)- but more generally known as loperamide oxide, which bears US NIH Compound Identifier 71421. European Medicines Agency schedules Loperamide oxide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08573MIG.

UNSPSC 51171725 Loperamide oxide monohydrate is a Commodity code that in practice covers drug testing services, specifically specimen collection and laboratory analysis for criminal justice and community supervision applications. State and local governments under this code procure offender drug screening and confirmation testing, including multi-panel immunoassay screening with instrumental confirmation (LC/MS/MS or GC/MS), alternative specimen types (oral fluid, hair), and associated staffing and electronic reporting infrastructure. The issuing bodies are primarily county community supervision and corrections departments managing probation and pretrial caseloads, which conduct high-volume randomized testing to monitor offender compliance.

Collin County Community Supervision and Corrections Department in Texas issued RFP 2026-327 for Offender Specimen Collection and Drug Testing Services with proposals due July 23, 2026. The scope encompasses operation of two collection sites in Plano and McKinney during standard business hours plus five Saturdays per year, an Interactive Voice Response system for randomized testing notifications, five-panel and six-panel screening with confirmatory testing, electronic result reporting, and alternative testing methodologies. The county anticipated approximately 25,031 annual tests across all service models, with an estimated contract value of $600,000 over a two-year initial term plus three optional one-year renewals. Vendors must hold lab certification from SAMHSA, Texas DPS, or CAP and must price services on a per-test basis with freight, delivery, insurance, and staffing included; price adjustments were permitted only on September 1 anniversaries based on medical Consumer Price Index increases capped at 3.0 percent annually. Award was anticipated for August 10, 2026, with funding from Texas Department of Criminal Justice-Community Justice Assistance Division appropriations.